Biomedical Engineering Reference
In-Depth Information
[303] Van Tomme SR, Hennink WE. Biodegradable dextran hydrogels for protein delivery
applications. Expert Rev Med Devices 2007;4:147-64.
[304] Lin CC, Metters A. Hydrogels in controlled release formulations: network design and
mathematical modeling. Adv Drug Deliv Rev 2006;58:1379-408.
[305] Chen FM, Zhao YM, Zhang R, Jin T, Sun HH, Wu ZF, et al. Periodontal regeneration
using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing
microspheres loaded with bone morphogenetic proteins. J Control Release 2007;121:
81-90.
[306] Chen RR, Silva EA, Yuen WW, Brock AA, Fischbach C, Lin AS, et al. Integrated
approach to designing growth factor delivery systems. FASEB J 2007;21:3896-903.
[307] Wei G, Jin Q, Giannobile WV, Ma PX. The enhancement of osteogenesis by nano-
fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 2007;28:2087-96.
[308] Tessmar JK, Goepferich AM. Matrices and scaffolds for protein delivery in tissue engi-
neering. Adv Drug Deliv Rev 2007;59:274-91.
[309] Suciati T, Howard D, Barry J, Everitt NM, Shakesheff KM, Rose FRAJ. Zonal release of
proteins within tissue engineering scaffolds. J Mater Sci Mater Med 2006;17:1049-56.
[310] Ungaro F, Biondi M, d'Angelo I, Indolfi L, Quaglia F, Netti PA, et al. Microsphere-inte-
grated collagen scaffolds for tissue engineering: effect of microsphere formulation and
scaffold properties on protein releasekinetics. J Control Release 2006;113:128-36.
[311] Jaklenec A, Wan E, Murray ME, Mathiowitz E. Novel scaffolds fabricated from pro-
tein-loaded microspheres for tissue engineering. Biomaterials 2008;29:185-92.
[312] Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. A novel pH-sensitive hydrogel
composed of
N
,
O
-carboxymethyl chitosan and alginate cross-linked by genipin for pro-
tein drug delivery. J Control Release 2004;96:285-300.
[313] Soppimath KS, Aminabhavi TM, Dave AM, Kumbar SG, Rudzinski WE. Stimulus-
responsive “smart” hydrogels as novel drug delivery systems. Drug Dev Ind Pharm
2002;28:957-74.
[314] Sabnis A, Wadajkar AS, Aswath P, Nguyen KT. Factorial analyses of photopolymer-
izable thermoresponsive composite hydrogels for protein delivery. Nanomedicine
2009;5:305-15.
[315] Davis BK. Control of diabetes with polyacrylamide implants containing insulin.
Experientia 1972;28:348.
[316] Davis BK. Diffusion in polymer gel implants. Proc Natl Acad Sci USA 1974;71:
3120-3.
[317] Sato S, Kim SW. Macromolecular diffusion through polymer implants. Int J Pharm 1984;
22:229-55.
[318] Sorensen RA, Peppas NA. Transport of macromolecules through model polymeric net-
works. Proc IUPAC Int Symp Macromol 1979;26:1108.
[319] Sanders LJ, Domb AJ. Delayed and sustained release devices for macromolecules—
especially polypeptide drugs, have partially hydrated hydrogel rate limiting membrane,
impermeable until fully hydrated
in situ
. Europe Patent Application 246653, 1987.
[320] Hassan CM, Peppas NA. Structure and applications of poly(vinyl alcohol) hydrogels
produced by conventional crosslinking or by freezing/thawing methods. In: Chang JY,
editor. Biopolymers/PVA hydrogels, anionic polymerisation nanocomposites, vol. 53.
Berlin/Heidelberg: Springer; 2000. p. 37-65.
[321] Torchillin VP, Tischenko EG, Smirnov VN, Chazov EI. Immobilization of enzymes on
slowly soluble carriers. J Biomed Res 1977;11:223-35.
[322] Lee F, Chung J, Kurisawa M. An injectable hyaluronic acid-tyramine hydrogel system
for protein delivery. J Control Release 2009;134:186-93.
Search WWH ::
Custom Search